Baillie Gifford & CO Codexis, Inc. Transaction History

Baillie Gifford & CO

$126 Billion
Q1 2024

A detailed history of Baillie Gifford & CO transactions in Codexis, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 3,445,309 shares of CDXS stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,445,309

Previous 3,419,093 0.77%

Holding current value

$11.6 Million

Previous $10.4 Million 15.3%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$2.59 - $4.65 $67,899 - $121,904	26,216 Added 0.77%	3,445,309 $12 Million
Q4 2023 Jan 26, 2024	SELL	$1.54 - $3.37 $970,929 - $2.12 Million	-630,474 Reduced 15.57%	3,419,093 $10.4 Million
Q3 2023 Nov 13, 2023	SELL	$1.5 - $3.75 $3.14 Million - $7.84 Million	-2,090,931 Reduced 34.05%	4,049,567 $7.65 Million
Q2 2023 Jul 28, 2023	BUY	$2.21 - $4.43 $73,104 - $146,539	33,079 Added 0.54%	6,140,498 $17.2 Million
Q1 2023 May 03, 2023	SELL	$3.81 - $6.76 $392,932 - $697,172	-103,132 Reduced 1.66%	6,107,419 $25.3 Million

Q4 2022 Jan 24, 2023	SELL	$4.26 - $6.84 $3.65 Million - $5.87 Million	-857,568 Reduced 12.13%	6,210,551 $28.9 Million
Q3 2022 Oct 27, 2022	SELL	$6.06 - $12.86 $2.01 Million - $4.27 Million	-331,948 Reduced 4.49%	7,068,119 $42.8 Million
Q2 2022 Aug 08, 2022	BUY	$8.35 - $21.89 $112,215 - $294,179	13,439 Added 0.18%	7,400,067 $77.4 Million
Q1 2022 May 05, 2022	BUY	$16.97 - $31.93 $3.47 Million - $6.52 Million	204,226 Added 2.84%	7,386,628 $152 Million
Q4 2021 Jan 20, 2022	BUY	$25.61 - $41.78 $14.4 Million - $23.5 Million	563,579 Added 8.51%	7,182,402 $225 Million
Q3 2021 Oct 19, 2021	SELL	$19.65 - $27.99 $722,176 - $1.03 Million	-36,752 Reduced 0.55%	6,618,823 $154 Million
Q2 2021 Aug 02, 2021	BUY	$17.48 - $25.46 $12.7 Million - $18.5 Million	725,024 Added 12.23%	6,655,575 $151 Million
Q1 2021 May 06, 2021	BUY	$18.08 - $28.8 $2.44 Million - $3.89 Million	135,153 Added 2.33%	5,930,551 $136 Million
Q4 2020 Feb 10, 2021	BUY	$11.7 - $23.41 $5.08 Million - $10.2 Million	434,137 Added 8.1%	5,795,398 $127 Million
Q3 2020 Nov 12, 2020	SELL	$11.21 - $13.82 $77,528 - $95,579	-6,916 Reduced 0.13%	5,361,261 $62.9 Million
Q2 2020 Aug 12, 2020	BUY	$9.8 - $12.77 $12.6 Million - $16.4 Million	1,280,860 Added 31.34%	5,368,177 $61.2 Million
Q1 2020 May 08, 2020	BUY	$8.78 - $18.6 $2.63 Million - $5.57 Million	299,283 Added 7.9%	4,087,317 $45.6 Million
Q4 2019 Feb 10, 2020	BUY	$13.12 - $17.06 $6.78 Million - $8.82 Million	516,934 Added 15.8%	3,788,034 $60.6 Million
Q3 2019 Nov 07, 2019	BUY	$12.75 - $19.01 $870,519 - $1.3 Million	68,276 Added 2.13%	3,271,100 $44.9 Million
Q2 2019 Aug 08, 2019	BUY	$17.0 - $21.88 $2.47 Million - $3.18 Million	145,269 Added 4.75%	3,202,824 $59 Million
Q1 2019 May 01, 2019	BUY	$15.53 - $22.15 $2.69 Million - $3.83 Million	173,065 Added 6.0%	3,057,555 $0
Q4 2018 Feb 14, 2019	BUY	$14.06 - $22.57 $1.17 Million - $1.88 Million	83,253 Added 2.97%	2,884,490 $48.2 Million
Q3 2018 Nov 13, 2018	BUY	$13.35 - $19.1 $2.07 Million - $2.96 Million	154,997 Added 5.86%	2,801,237 $48 Million
Q2 2018 Jul 17, 2018	BUY	$10.35 - $16.45 $3.55 Million - $5.65 Million	343,261 Added 14.91%	2,646,240 $38.1 Million
Q1 2018 May 10, 2018	BUY	$8.0 - $12.8 $3.68 Million - $5.9 Million	460,578 Added 25.0%	2,302,979 $25.3 Million
Q4 2017 Feb 13, 2018	BUY	$5.85 - $8.4 $2.13 Million - $3.06 Million	364,304 Added 24.65%	1,842,401 $15.4 Million
Q3 2017 Oct 20, 2017	BUY	$4.9 - $6.65 $81,751 - $110,948	16,684 Added 1.14%	1,478,097 $9.83 Million
Q2 2017 Aug 10, 2017	BUY	N/A	1,461,413	1,461,413 $7.97 Million

Others Institutions Holding CDXS

# of Institutions

131

Shares Held

49.5M

Call Options Held

33.4K

Put Options Held

21K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $221M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Codexis, Inc. Transaction History